Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Practical issues in drug selection and dosing.

H W Schnaper1

  • 1Department of Medicine, University of Alabama, Birmingham 35294.

The American Journal of Cardiology
|January 17, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A few kind words for the Devil.

Journal of religion and health·2014
Same author

Serine-204 in the linker region of Smad3 mediates the collagen-I response to TGF-β in a cell phenotype-specific manner.

Experimental cell research·2013
Same author

Estradiol enhances endothelial cell interactions with extracellular matrix proteins via an increase in integrin expression and function.

Angiogenesis·2003
Same author

Talking at cross purposes: molecular interactions downstream from TGF-beta.

Kidney international·2001
Same author

Risk factors for cardiovascular disease in children on maintenance dialysis.

Advances in renal replacement therapy·2001
Same author

Antithrombin III, protein S, and coagulation in the nephrotic syndrome.

Pediatric nephrology (Berlin, Germany)·2001

Current guidelines suggest nonpharmacologic treatment for hypertension initially. Drug therapy is recommended for persistent high blood pressure, with specific first-line options for different patient groups, prioritizing safety and efficacy.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Hypertension management guidelines recommend initiating antihypertensive therapy at diastolic blood pressure >90 mm Hg after nonpharmacologic measures fail.
  • Elevated blood pressure, whether systolic, diastolic, or both, increases the risk of heart attack and stroke.

Purpose of the Study:

  • To outline current recommendations for initiating antihypertensive therapy.
  • To detail the initial approach for managing mild to moderate hypertension and for prevention in normotensive individuals with a family history.
  • To specify first-line drug choices and titration strategies based on patient demographics and comorbidities.

Main Methods:

  • Review of current clinical guidelines for hypertension management.
  • Analysis of evidence supporting nonpharmacologic and pharmacologic interventions.

Related Experiment Videos

  • Stratification of treatment recommendations by patient age, blood pressure profile, and specific conditions like tachycardia.

    • Main Results:

    • Nonpharmacologic measures are the initial approach for mild to moderate hypertension and in prevention programs.
    • For patients remaining hypertensive, drug therapy is indicated.
    • Low-dose thiazide diuretics are preferred for elderly patients; beta-blockers may be considered for patients under 40 with tachycardia.
    • Treatment initiation should be with less than a full dose, titrating as necessary.
    • Potassium-sparing diuretics are recommended if extrasystoles or low potassium levels (<3.5 mEq/L) occur in the elderly.

    Conclusions:

    • Current guidelines provide a stepwise approach to hypertension management, starting with nonpharmacologic methods.
    • Pharmacologic therapy selection and titration should be individualized based on patient characteristics.
    • Careful monitoring of electrolytes, particularly potassium, is crucial during diuretic therapy to mitigate risks like arrhythmias.